3家公司全部大涨 还有3家暗盘大涨！2026年港股IPO迎开门红

Core Insights - Three companies, Zhipu, Tianshu Zhixin, and Jingfeng Medical-B, successfully listed on the Hong Kong Stock Exchange on January 8, 2026, with first-day gains of 13.17%, 8.44%, and 30.90% respectively [1][3][4]. Group 1: Company Performance - Zhipu, as the world's first publicly listed company focused on general artificial intelligence (AGI) foundational models, has gained significant attention from investors. The company supports over 8,000 institutional clients and approximately 80 million devices, holding a market share of 6.6% among independent AGI developers in China [5][6]. - Tianshu Zhixin specializes in general GPU products and AI computing solutions, delivering over 52,000 GPU products to more than 290 clients across various industries. The company has achieved over 900 deployments in critical sectors such as financial services and healthcare [6][7]. - Jingfeng Medical-B, established in 2017, is a leading surgical robotics company in China, recognized for its advanced multi-port and single-port laparoscopic surgical robots. The company has secured regulatory approval for its MP1000 model and has signed sales agreements for 31 units as of June 30, 2025 [7][8]. Group 2: Market Reception - The initial public offerings (IPOs) of these three companies were met with strong demand, with Zhipu and Jingfeng Medical-B experiencing over 1,000 times oversubscription in their public offerings, while Tianshu Zhixin had an oversubscription of 414.24 times [8][9]. - The strong performance of these IPOs has contributed to a positive sentiment in the Hong Kong IPO market, with expectations that upcoming listings may also perform well [4][11]. Group 3: Institutional Interest - All three companies attracted significant interest from institutional investors, with Zhipu securing a diverse base of cornerstone investors, including major public funds and private equity firms, raising a total of HKD 29.8 billion [9][10]. - Tianshu Zhixin and Jingfeng Medical-B also have backing from prominent institutions such as UBS and the Abu Dhabi Investment Authority, indicating strong confidence in their business models and growth potential [10]. Group 4: Upcoming Listings - The Hong Kong market is experiencing a surge in new listings, with additional companies set to debut shortly after the successful IPOs of Zhipu, Tianshu Zhixin, and Jingfeng Medical-B, indicating a robust pipeline for the market [11][12].